Prospects For the Use of Peptides against Respiratory Syncytial Virus

The human respiratory syncytial virus (RSV) is one of the most common viral pathogens that affects the lower respiratory tract and could be a reason of bronchiolitis and/or pneumonia. Currently, there are no available effective ways of treating the RSV infection. Attempts to develop preventive vacci...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular biology (New York) 2019-07, Vol.53 (4), p.484-500
Hauptverfasser:	Shilovskiy, I. P., Andreev, S. M., Kozhikhova, K. V., Nikolskii, A. A., Khaitov, M. R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral activity Antiviral agents Biochemistry Biomedical and Life Sciences Bronchopneumonia Cathelicidins Clinical trials Defensins Epithelium Herpes simplex HIV Human Genetics Human immunodeficiency virus Immunoregulation Influenza Inhalation Life cycles Life Sciences Monoclonal antibodies Peptides Respiratory syncytial virus Respiratory tract Reviews Ribavirin Toxicity Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!